449 related articles for article (PubMed ID: 26158804)
1. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
Bielski ER; Zhong Q; Brown M; da Rocha SR
Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
[TBL] [Abstract][Full Text] [Related]
2. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
3. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria.
Biswas S; Dodwadkar NS; Piroyan A; Torchilin VP
Biomaterials; 2012 Jun; 33(18):4773-82. PubMed ID: 22469294
[TBL] [Abstract][Full Text] [Related]
4. PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations.
Yang L; da Rocha SR
Mol Pharm; 2014 May; 11(5):1459-70. PubMed ID: 24679335
[TBL] [Abstract][Full Text] [Related]
5. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
6. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
7. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.
Sharma A; Liaw K; Sharma R; Zhang Z; Kannan S; Kannan RM
Theranostics; 2018; 8(20):5529-5547. PubMed ID: 30555562
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers.
Guzman-Villanueva D; Mendiola MR; Nguyen HX; Yambao F; Yu N; Weissig V
Methods Mol Biol; 2019; 2000():183-189. PubMed ID: 31148015
[TBL] [Abstract][Full Text] [Related]
9. Effect of Protein Corona on Mitochondrial Targeting Ability and Cytotoxicity of Triphenylphosphonium Conjugated with Polyglycerol-Functionalized Nanodiamond.
Zou Y; Nishikawa M; Kang HG; Cheng G; Wang W; Wang Y; Komatsu N
Mol Pharm; 2021 Jul; 18(7):2823-2832. PubMed ID: 34165304
[TBL] [Abstract][Full Text] [Related]
10. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizer-mediated mitochondria-targeting nanosized drug carriers: Subcellular targeting, therapeutic, and imaging potentials.
Choi YS; Kwon K; Yoon K; Huh KM; Kang HC
Int J Pharm; 2017 Mar; 520(1-2):195-206. PubMed ID: 28179191
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.
Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR
Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560
[TBL] [Abstract][Full Text] [Related]
14. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
15. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of mitochondria-targeted polymeric nanoparticles.
Marrache S; Pathak RK; Dhar S
Methods Mol Biol; 2015; 1265():103-12. PubMed ID: 25634270
[TBL] [Abstract][Full Text] [Related]
17. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
Zhong Q; da Rocha SR
Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
[TBL] [Abstract][Full Text] [Related]
18. Redox and pH-responsive poly (amidoamine) dendrimer-poly (ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release.
Hu W; Cheng L; Cheng L; Zheng M; Lei Q; Hu Z; Xu M; Qiu L; Chen D
Colloids Surf B Biointerfaces; 2014 Nov; 123():254-63. PubMed ID: 25277289
[TBL] [Abstract][Full Text] [Related]
19. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles.
Maghsoudnia N; Baradaran Eftekhari R; Naderi Sohi A; Norouzi P; Akbari H; Ghahremani MH; Soleimani M; Amini M; Samadi H; Dorkoosh FA
J Drug Target; 2020; 28(7-8):818-830. PubMed ID: 32452217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
